On Biostatistics and Clinical Trials

CQ's web blog on the issues in biostatistics and clinical trials.

Tuesday, January 20, 2009

Multiple Comparisons

›
In statistics or biostatistics, the multiple comparisons problem occurs when one considers a set, or family, of statistical inferences simul...
1 comment:
Monday, January 19, 2009

Trial Biomarker Analysis More Than Data Dredging

›
members of the FDA's oncology Drugs Advisory Committee cautioned sponsors against treating retrospective clinical trial biomarker analys...

Data dredging vs. Data mining; Post-hoc vs. Ad-hoc

›
Data dredging (data fishing, data snooping) is the inappropriate (sometimes deliberately so) search for 'statistically significant'...
2 comments:
Sunday, January 11, 2009

EQ-5D

›
EQ-5D is a standardized instrument for use as a measure of health outcome. Applicable to a wide range of health conditions and treatments, i...

9 ways to stay alive when the worst happens

›
The followings are copied from PARADE (Jan 11, 2009). I am not sure if these arguments (or suggestions) have any scientific merit, but I cop...
Tuesday, January 06, 2009

FDAAA and clinical trial data bases

›
The recently-enacted FDA Amendments Act (“FDAAA”) has lots of requirements that may have impact on statistical analysis and programming. It...
Wednesday, December 31, 2008

Significance of the Correlation Coefficient

›
People can be confused about the interpretation of the correlation coefficient, especially when we observe a small, but statistically signif...
1 comment:

LogMAR in Ophthalmology trials

›
Vision is typically reported as xxx/yyy where the xxx value is usually 20 for US assessments. As vision gets worse, for the same numerator, ...
1 comment:

AstraZeneca considers pursuing "biosimilars."

›
From " http://www.delawareonline.com/article/20081230/BUSINESS/812300331 " AstraZeneca is considering joining several of its peers...
Thursday, November 20, 2008

Biosimilar

›
Biosimilars or Follow-on biologics are terms used to describe officially approved new versions of innovator biopharmaceutical products, fo...
Sunday, November 16, 2008

Herbal medicine

›
I have been thought that the chinese traditional medicine from herbal is typically safe. However, recent discussions with my friends make me...
1 comment:
Wednesday, November 12, 2008

Analysis Problems with Subgroup Analyses

›
Sub-grouping damages the balance obtained by randomization If the randomization is stratified for one factor (for example, disease severity)...
Thursday, November 06, 2008

FDA Revises Process for Responding to Drug Applications

›
The following annoucement really makes sense. Previously, FDA could issue an "approvable" letter that could be very confusing. A p...
1 comment:
Wednesday, November 05, 2008

PRO, CRO, and Laboratory tests / device measurements

›
In an article by Willke et al (Controlled Clinical Trials, 25, 2004), the study endpoints were classified as three major categories. Endpoin...
Tuesday, November 04, 2008

Declaration of Helsinki and FDA

›
The newly released Declaration of Helsinki was issued by the 59th World Medical Association General Assembly in October 2008. This document ...
2 comments:
Tuesday, October 07, 2008

Power of words and Safe Communication

›
Words that end up in court Altered records, defect, falsification, hazardous, illegal, incompetence, inferior, negligent, reckless, wrongdoi...
Monday, October 06, 2008

Source data in EDC trial

›
One of my friends asked me what would be the source data and how to verify if the data was directly entered into EDC. A recent article in cl...

New Data Management acronyms

›
The recent effort to standardize the clinical data acquisition results in a lot of new acronyms . Some of them are listed below. A lot of th...

Adobe Acrobat Resource Center - weblinks

›
Training & Resources: Acrobat for life sciences blog - http://blogs.adobe.com/acrobatforlifesciences/ Acrobat legal links online - https...
Sunday, October 05, 2008

Introduction to pharmacokinetics and pharmacodynamics

›
The book by Drs Tozer and Rowland is pretty good. About dose "To paraphrase Paracelsus, who lived some 500 years ago, "all drugs a...
1 comment:
‹
›
Home
View web version

About Me

My photo
Web blog from Dr. Deng
Chapel Hill, NC, United States
邓春勤 A Medical Doctor turned into Biostatistician in Clinical Trial and Drug Development Industry
View my complete profile
Powered by Blogger.